Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negrin

Showing results (101-110 of 260) with videos related to

Pageof 26
Sort By:
Annals of Internal Medicine|June 15, 1989
Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trialR S Negrin, D H Haeuber, A Nagler, et al.
Molecular Imaging|May 15, 2004
Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcomeStefanie J Mandl, Carina Mari, Matthias Edinger, et al.
Blood|March 9, 2006
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 productionRobert Zeiser, Vu H Nguyen, Andreas Beilhack, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2013
IL-17 gene ablation does not impact Treg-mediated suppression of graft-versus-host disease after bone marrow transplantationLucrezia Colonna, Mareike Florek, Dennis B Leveson-Gower, et al.
Blood|October 28, 2006
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host diseaseRobert Zeiser, Vu H Nguyen, Jing-Zhou Hou, et al.
Blood|April 1, 1997
Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donorsC R Kusnierz-Glaz, B J Still, M Amano, et al.
Blood|January 25, 2011
Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanismDennis B Leveson-Gower, Janelle A Olson, Emanuela I Sega, et al.
JCI Insight|June 19, 2019
Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathwayMaite Alvarez, Federico Simonetta, Jeanette Baker, et al.
Blood|October 6, 2007
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantationVu H Nguyen, Sumana Shashidhar, Daisy S Chang, et al.
Cancer Research|October 12, 2010
Definition of an enhanced immune cell therapy in mice that can target stem-like lymphoma cellsChristopher H Contag, Rachel Sikorski, Robert S Negrin, et al.
Pageof 26

Showing results (101-110 of 260) with videos related to

Sort By:
Pageof 26
Annals of Internal Medicine|June 15, 1989
Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trialR S Negrin, D H Haeuber, A Nagler, et al.
Molecular Imaging|May 15, 2004
Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcomeStefanie J Mandl, Carina Mari, Matthias Edinger, et al.
Blood|March 9, 2006
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 productionRobert Zeiser, Vu H Nguyen, Andreas Beilhack, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2013
IL-17 gene ablation does not impact Treg-mediated suppression of graft-versus-host disease after bone marrow transplantationLucrezia Colonna, Mareike Florek, Dennis B Leveson-Gower, et al.
Blood|October 28, 2006
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host diseaseRobert Zeiser, Vu H Nguyen, Jing-Zhou Hou, et al.
Blood|April 1, 1997
Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donorsC R Kusnierz-Glaz, B J Still, M Amano, et al.
Blood|January 25, 2011
Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanismDennis B Leveson-Gower, Janelle A Olson, Emanuela I Sega, et al.
JCI Insight|June 19, 2019
Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathwayMaite Alvarez, Federico Simonetta, Jeanette Baker, et al.
Blood|October 6, 2007
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantationVu H Nguyen, Sumana Shashidhar, Daisy S Chang, et al.
Cancer Research|October 12, 2010
Definition of an enhanced immune cell therapy in mice that can target stem-like lymphoma cellsChristopher H Contag, Rachel Sikorski, Robert S Negrin, et al.
Pageof 26